Recombinant Mouse Mast Cell Protease-1/Mcpt1 Protein, CF

Catalog #: 5146-SE Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
5146-SE-010

R&D Systems Recombinant Proteins and Enzymes

1 Image

All Mast Cell Protease-1/Mcpt1 Proteins and Enzymes

Product Details

Supplemental Products

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Mouse Mast Cell Protease-1/Mcpt1 Protein, CF Summary

Product Specifications

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

Activity

Measured by its ability to cleave Suc-Ala-Ala-Pro-Phe-AMC (Suc-AAPF-AMC, Bachem, Catalog # I-1465). The specific activity is >35 pmol/min/µg, as measured under the described conditions.

Source

Mouse myeloma cell line, NS0-derived mouse Mast Cell Protease-1/Mcpt1 protein
Glu19-Lys246, with a C-terminal 10-His tag

Accession #

P11034

N-terminal Sequence
Analysis

Glu19

Structure / Form

Pro form

Predicted Molecular Mass

27 kDa

SDS-PAGE

33 kDa, 35 kDa and 36 kDa, reducing conditions

Product Datasheets

5146-SE

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

5146-SE

Formulation	Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials

Activation Buffer: 50 mM MES, 50 mM NaCl, 5 mM DTT, pH 5.5
Assay Buffer: 50 mM Tris, 2 M NaCl, 0.025% (w/v) Brij-35, pH 8.0
Recombinant Mouse Mast Cell Protease‑1/Mcpt1 (rmMcpt1) (Catalog # 5146-SE)
Recombinant Mouse Active Cathepsin C/DPPI (rmCathepsin C) (Catalog # 2336-CY)
Heparin (Sigma, Catalog # H3393), 20 mg/mL stock in deionized water
N-Ethylmaleimide (NEM) (Sigma, Catalog # E1271), 50 mM stock in deionized water
Substrate: SUC-Ala-Ala-Pro-Phe-AMC (Bachem, Catalog # I-1465), 10 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent

Dilute rmCathepsin C to 120 µg/mL in Activation Buffer.
Dilute rmMcpt1 to 200 µg/mL in Activation Buffer.
Dilute Heparin to 160 µg/mL in Activation Buffer.
Combine 15 µL of 200 µg/mL rmMcpt1, 15 µL of 120 µg/mL rmCathepsin C and 30 µL of 160 µg/mL Heparin. Mix well.
Incubate reaction mixture for 2 hours at 37 °C.
Dilute NEM to 10 mM in Assay Buffer.
Stop activation by adding 60 µL of 10 mM NEM.
Dilute activated rmMcpt1 to 8 ng/µL in Assay Buffer.
Dilute Substrate to 200 µM in Assay Buffer.
Load into a plate 50 µL of 8 ng/µL rmMcpt1, and start the reaction by adding 50 µL of 200 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of 200 µM Substrate.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.

Specific Activity (pmol/min/µg) =	Adjusted V_max* (RFU/min) x Conversion Factor** (pmol/RFU)
	amount of enzyme (µg)

*Adjusted for Substrate Blank
**Derived using calibration standard 7-Amino, 4-Methyl Coumarin (AMC) (Sigma, Catalog # A-9891).

Per Well:

rmMcpt1: 0.4 µg
Substrate: 100 µM

Reconstitution Calculator

Background: Mast Cell Protease-1/Mcpt1

Mast cell protease-1 (Mcpt1), also known as beta ‑chymase, is a member of the Chymase family of chymotrypsin-like serine proteases (1). mMcpt1 is a mast cell protease predominantly expressed in intestinal mucosal mast cells where it promotes mucosal permeability in intestinal allergic hypersensitivity reactions (2). Its activation is completed by the removal of a two residue N‑terminal propeptide by a dipeptidyl peptidase (Cathepsin C) (3). Like human alpha ‑Chymase, Mcpt1 is capable of the conversion of angiotensin I to angiotensin II, which plays a key role in the regulation of arterial pressure (4). Studies have shown that specific chymase inhibitors are able to diminish the development of abdominal aortic aneurysm and reduce the adhesion formation after cardiac surgery in hamsters (5, 6). Therefore, the development of specific inhibitors of chymase activity has been a pharmacologic strategy to develop therapeutic agents.

References

Caughey, G.H. (2004) in Handbook of Proteolytic Enzymes (ed. Barrett, et al.), p. 1531 Academic Press, San Diego.
Wastling, J.M. et al. (1998) Am. J. Pathol. 153:491.
Murakami, M. et al. (1995) J. Biol. Chem. 270:2218.
Saito, K. et al. (2003) Biochem. Biophys. Res. Commun. 302:773.
Tsunemi, K. et al. (2004) J. Pharmacol. Exp. Ther. 309:879.
Soga, Y. et al. (2004) J. Thorac. Cardiovasc. Surg. 127:72.